Listing & Compliance Notices

Triller Group Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 17, 2025, Triller Group Inc. (“Triller”) received a delinquency notification letter (the “Notice”) from the Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market LLC (“ Nasdaq ”) due to the Company’s non-compliance with Nasdaq Listing Rule 5250(c)(1) (the “ Listing Rule ”) as a result of the Company’s failure to timely file its Annual Report on Form 10-K for the period ended December 31, 2024 (the “ Filing ”). The Listing Rule requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “ SEC ”). This No”

Laser Photonics Corp received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 16, 2025, the registrant (“Laser Photonics” or the “Company”) received a notice from Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that since the Company has not yet filed its Form 10-K for the year ended December 31, 2023 (the “Filing”), it no longer complies with Nasdaq’s Listing Rules (the “Rules”), specifically Listing Rule 5250(c)(1), for continued listing. Under the Rules, the Company has 60 calendar days to submit a plan to regain compliance, and if Nasdaq accepts the Company’s plan, Nasdaq can grant an exception of up to 180 calendar d”

SYNTEC OPTICS HOLDINGS, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 16, 2025, Syntec Optics Holdings, Inc. (the “Company”) received a delinquency notification letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that since it has not yet filed its Form 10-K for the year ended December 31, 2024 the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires listed companies to timely file all periodic financial reports with the U.S. Securities and Exchange Commission. The Letter states that the Company now has 60 calendar days to submit a plan to regain compli”

Ocean Biomedical, Inc. received a nasdaq delisting notice notice regarding other.

“April 22, 2025, Ocean Biomedical, Inc. received a letter from Nasdaq determining that OCEA’s common stock will be delisted from Nasdaq and that trading in its securities will be suspended effective upon the open of business on April 24, 2025. The letter also stated that Nasdaq intends to complete delisting by filing a Form 25 Notification of Delisting with the SEC after applicable appeal periods have lapsed. Pursuant to Nasdaq listing rules, the Company has the right to appeal Nasdaq’s delisting determination within 15 days of the date of the letter. The Company intends to file its appeal fort”

ConnectM Technology Solutions, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 17, 2025, ConnectM Technology Solutions, Inc., a Delaware corporation (“ ConnectM ” or the “ Company ”), received a letter (the “ Letter ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that it is not in compliance with the Securities and Exchange Commission (the “ SEC ”) periodic reporting requirements for continued listing, as set forth in Nasdaq Listing Rule 5250(c)(1), because the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “ 2024 10-K ”), was not filed with the SEC by the require”

Brag House Holdings, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 17, 2025, Brag House Holdings, Inc., (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is not in compliance with periodic requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) (the “Listing Rule”) because the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “2024 10-K”) was not filed with the Securities and Exchange Commission by the required due date of April 15, 2025. As a result of this delinquency of not timely fil”

Yotta Acquisition Corp received a nasdaq delisting notice notice regarding other (rules IM-5101-2, 5250(f), 5810(d)(2)).

“April 28, 2025; and (iii) a Form 25-NSE will be filed with the Securities and Exchange Commission (the “SEC”), which will remove the Company’s securities from listing and registration on the Nasdaq Stock Market. Pursuant to Nasdaq Listing Rule IM-5101-2, a special purpose acquisition company must complete one or more business combinations within 36 months of the effectiveness of its IPO registration statement. Since the Company failed to complete its initial business combination by April 19, 2025, the Company did not comply with IM-5101-2, and its securities are now subject to delisting. Addit”

ScanTech AI Systems Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 17, 2025, ScanTech AI Systems Inc. (the “Company”) received a deficiency letter (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the requirements of Nasdaq Listing Rule 5250(c)(1) as a result of not having timely filed with the U.S. Securities and Exchange Commission its Annual Report on Form 10-K for the year ended December 31, 2024 (the “Annual Report”). The Notice has no immediate effect on the listing of the Company’s common stock on The Nasdaq Global Market. The Notice stated that the Company has 60 calendar days to s”

SMITH MIDLAND CORP received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“April 17, 2025, Smith-Midland Corporation (the “Company”) received a letter from Nasdaq indicating that it was not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires the timely filing of all required periodic financial reports with the Securities and Exchange Commission. The required filing in question is the Company’s Annual Report in Form 10-K for the year ended December 31, 2024 (the “Form 10-K”). As referenced in the Company’s recent filing of Form 12b-25, the delay in filing the Form 10-K is related to the Company requiring additional time to complete its financial reportin”

CHARLES & COLVARD LTD received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“April 16, 2025, the Company received a staff determination letter (the “Letter”) from the Listing Qualifications staff (the “Staff”), which states that, since the Company did not file the Forms 10-Q prior to the Extension Date, the Company is out of compliance with the Listing Rule. The Company does not intend to appeal the Staff’s determination. As a result, trading of the Company’s common stock will be suspended from The Nasdaq Capital Market at the opening of business on April 25, 2025, and a Form 25-NSE will be filed with the SEC, which will remove the Company’s securities from listing and”

MARIN SOFTWARE INC received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 16, 2025, Marin Software Incorporated, a Delaware corporation (the “Company”), received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it was not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of its failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Form 10-K”). The Notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Capital”

ADDENTAX GROUP CORP. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“nt (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share of its common stock was below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). The Nasdaq letter does not result in the immediate delisting of the Company’s shares of common stock, and the shares will continue to trade uninterrupted under the symbol “ATXG.” Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance pe”

GameSquare Holdings, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 16, 2025, the Company received a second notice (the “Second Notice”) from Nasdaq indicating that, while the Company has not yet regained compliance with the Bid Price Rule, the Staff has determined that the Company is eligible for an additional 180 calendar day period, or until October 13, 2025 (the “Second Compliance Period”), to regain compliance. According to the Second Notice, the Staff’s determination was based on (i) the Company meeting the continued listing requirement for market value of publicly held shares and all other applicable requirements for initial listing on the Nasdaq”

Evolv Technologies Holdings, Inc. received a nasdaq noncompliance notice notice regarding late filing (rules 5250(c)(1)).

“April 16, 2025, Evolv Technologies Holdings, Inc. (the “Company”) received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company was not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Nasdaq Listing Rule”) as a result of the delayed filing of the Company’s Annual Report on Form 10-K for the period ended December 31, 2024 (the “Annual Report”). The Company previously submitted a plan to regain compliance with the Nasdaq Listing Rule to Nasdaq in connection with an earlier notice of non-complian”

KORE Group Holdings, Inc. received a nyse deficiency notice notice regarding late filing (rules 802.01E).

“April 16, 2025, KORE Group Holdings, Inc. (the “Company”) received a notice (the “NYSE Notice”) from the New York Stock Exchange (the “NYSE”) that the Company is not in compliance with Section 802.01E of the NYSE Listed Company Manual as a result of its failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “Form 10-K”) with the Securities and Exchange Commission (the “SEC”). The NYSE Notice has no immediate effect on the listing of the Company’s common stock on the NYSE. The NYSE Notice informed the Company that, under NYSE rules, the Company ha”

Solo Brands, Inc. received a nyse delisting notice notice regarding other (rules 802.01D).

“April 22, 2025, the New York Stock Exchange (the “NYSE”) notified Solo Brands, Inc. (the “Company”), and publicly announced, that it had determined to commence proceedings to delist the Company’s Class A common stock, par value $0.001 per share (the “Class A Common Stock”), as a result of the Company’s non-compliance with Rule 802.01D of the NYSE Listed Company Manual due to the Class A Common Stock trading at “abnormally low price” levels and that trading in the Class A Common Stock was suspended immediately. The NYSE will apply to the Securities and Exchange Commission (the “SEC”) to delist”

Solidion Technology Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C), 5810(c)(3)(D)).

“April 16, 2025, Solidion Technology, Inc. (the “ Company ”) received notice (the “ Notice ”) from the Listing Qualifications staff of the Nasdaq Stock Market LLC (“ Nasdaq ”) due to the Company’s noncompliance with Nasdaq Listing Rules 5450(b)(2)(C). The Notice cites the Company’s not being in compliance with the minimum Market Value of Publicly Held Shares (“ MVPHS ”) requirement as set forth in Nasdaq Listing Rule 5450(b)(2)(C). Pursuant to Nasdaq Listing Rule 5810(c)(3)(D), the Company has a compliance period of 180 calendar days, or until October 13, 2025, to regain compliance with the MVP”

Northann Corp. received a nyse_american deficiency notice notice regarding late filing (rules 134, 1101, 1007).

“ions 134 and 1101 of the NYSE American Company Guide due to its delayed filings of the Form 10-K for the year ended December 31, 2024 (the “Delinquent Report”) by the filing due date of April 15, 2025 (the “Filing Delinquency”). Reference is made to the Company’s Notification of Late Filing on Form 12b-25 (filed with the SEC on March 31, 2025), which described the circumstances leading to the late filing of the Delinquent Report. Although the Company has dedicated significant resources to the completion of finalizing its consolidated financial statements and related disclosures for inclusion i”

Scorpius Holdings, Inc. received a nyse_american noncompliance notice notice regarding late filing (rules 1007).

“April 16, 2025 Notification On April 16, 2025, Scorpius Holdings, Inc. (the “Company”) received a notice (the “Notice”) from the NYSE Regulation (the "Notice") stating that the Company is not in compliance with the continued listing standards of the NYSE American LLC (the "Exchange") under the timely filing criteria included in Section 1007 of the NYSE American Company Guide (the "Company Guide") because the Company failed to timely file its Annual Report on Form 10-K for the year ended December 31, 2024 (the "Delinquent Report"), which was due to be filed with the Securities and Exchange Comm”

Village Farms International, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“eviously reported, on October 18, 2024, Village Farms International, Inc. (the “ Company ”) received notification from The Nasdaq Stock Market LLC (“ Nasdaq ”) that it is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market (Nasdaq Listing Rule 5550(a)(2)) (the “ Minimum Bid Requirement ”) as the bid price for the Company’s common shares (the “ Common Shares ”) closed below US$1.00 from September 6, 2024 to October 17, 2024. Pursuant to this notification, the Company had an initial 180-calendar day period to regain compliance with the Mini”

Cambium Networks Corp received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 16, 2025, Cambium Networks Corporation (the “Company”) received a deficiency letter (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the requirements of Nasdaq Listing Rule 5250(c)(1) as a result of not having timely filed with the U.S. Securities and Exchange Commission its Form 10-K for the year ended December 31, 2024 (the “Form 10-K”). The Notice has no immediate impact on the listing of the Company’s ordinary shares on Nasdaq, and the Company’s listing remains fully effective. As a non-compliant company, an indicator”

Energy Vault Holdings, Inc. received a nyse noncompliance notice notice regarding minimum bid price (rules 802.01C).

“April 16, 2025, indicating that Energy Vault is not in compliance with Section 802.01C of the NYSE Listed Company Manual because the average closing price of Energy Vault’s common stock was less than $1.00 over a consecutive 30 trading-day period. Under NYSE rules, Energy Vault has a period of six months from receipt of the notice to regain compliance with the NYSE minimum stock price listing requirement. Energy Vault plans to notify the NYSE by May 1, 2025, of its intent to cure the stock price deficiency and return to compliance with the NYSE continued listing standards. Energy Vault intends”

Nuvve Holding Corp. received a nasdaq deficiency notice notice regarding board independence (rules 5605, 5605(b)(1)(A), 5605(c)(4)).

“April 15, 2025, Nuvve Holding Corp. (the “Company”), received written notice (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, as a result of Angela Strand’s resignation from the Board of Directors of the Company (the “Board”) and the audit committee of the Board (the “Audit Committee”), effective April 1, 2025, the Company is not currently in compliance with Nasdaq Listing Rule 5605. Nasdaq Listing Rule 5605 requires that (i) a majority of the Board be comprised of independent directors and (ii) the Audit Committee”

ALPHATIME ACQUISITION CORP received a nasdaq noncompliance notice notice regarding market value (rules 5450(b)(2)(A)).

“April 17, 2025, AlphaTime Acquisition Corp (the “ Company ”) received a letter (the “ Notice ”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“ Nasdaq ”) notifying the Company that, for the last 30 consecutive business days, the Minimum Value of Listed Securities, as defined by Nasdaq (“ MVLS ”), of the Company’s ordinary shares, par value $0.0001 per share (the “ Ordinary Shares ”), has been below the minimum $50 million requirement for continued listing on The Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “ Minimum Market Value of Listed Secur”

iCoreConnect Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 16, 2025, iCoreConnect Inc. (the “Company”) received a letter (the “Letter”) from the staff of the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”), which notified the Company that since it had not yet filed its Form 10-K for the period ended December 31, 2024, it no longer complied with Nasdaq Listing Rule 5250(c)(1) for continued listing. The Staff indicated that this matter would serve as an additional basis for delisting the Company’s securities. The Staff advised the Company that the Nasdaq Hearings Panel (“Panel”) that heard the Company’s su”

Greenland Mines Ltd received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“October 15, 2024, the Company received a delinquency notification letter (the “Notice”) from Nasdaq due to the Company’s non-compliance with Nasdaq Listing Rule 5450(a)(1). The Notice cited the fact that the bid price of the Company’s common stock had closed at less than $1 per share over the previous 30 consecutive business days. B. On April 15, 2025, the Company received written notice (the “April 15 Notice”) from the Nasdaq stating that the Company has not regained compliance with the Rule. The April 15 Notice also stated that the Panel will consider this matter in their decision regarding”

Greenland Mines Ltd received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C), 5450(b)(2)(A), 5810(c)(3)(D)).

“August 16, 2024, Klotho Neurosciences, Inc. (the “Company”) received two delinquency notification letters (the “Notices”) from The Nasdaq Stock Market LLC (“Nasdaq”) due to the Company’s non-compliance with Nasdaq Listing Rules 5450(b)(2)(C) and 5450(b)(2)(A). The Notices cite the Company for not being in compliance with the minimum Market Value of Publicly Held Shares (“MVPHS”) requirement, as set forth in Nasdaq Listing Rule 5450(b)(2)(C), and for not being in compliance with the minimum Market Value of Listed Securities (“MVLS”) requirement, as set forth in Nasdaq Listing Rule 5450(b)(2)(A)”

Thunder Power Holdings, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5450(a)(1), 5450(b)(2)(A)).

“April 8, 2025, the Company received an additional Staff delist determination letter, outlining a new concern that the Staff believed the Company is a public shell. A hearing was held on April 15, 2025 as originally scheduled, which is by the Delisting Notice two days thereafter. Trading of the Company’s securities on the Pink Tier of the OTC market is expected to commence shortly after the Company’s securities are delisted from Nasdaq on April 21, 2025. 1 SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on i”

LIXTE BIOTECHNOLOGY HOLDINGS, INC. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

“April 17, 2025, the Company received notice that the Nasdaq Hearings Panel (the “Panel”) had granted the Company an extension in which to regain compliance with all continued listing rules of the Nasdaq Capital Market. The Panel’s determination follows a hearing on April 3, 2025, at which the Panel considered the Company’s plan to regain compliance with the Equity Rule. As a result of the extension, the Panel granted the Company’s request for continued listing on the Nasdaq Capital Market, provided that the Company demonstrates compliance with the Equity Rule and all other continued listing re”

INVO Fertility, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 16, 2025, INVO Fertility, Inc. (the “Company”), formerly known as NAYA Biosciences, Inc., received a letter (the “Letter”) from the Listing Qualifications staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company failed to file its Annual Report on Form 10-K for the year ended December 31, 2024 (the “Filing”), on a timely basis and, as such, no longer satisfies Nasdaq Listing Rule 5250(c)(1) (the “Rule”). The Letter has no immediate effect on the listing of the Company’s common stock and the Company’s common stock continues to trade on The Nasdaq Capital M”

FiEE, Inc. received a nasdaq deficiency notice notice regarding other.

“April 7, 2025 Letter (as defined below) the Company received from the Nasdaq (as defined below), in addition to the Additional Deficiencies (as defined below) identified in the Original Form 8-K. Item 3.01 of the Original Form 8-K is hereby restated in its entirety and”

Lunai Bioworks Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 14, 2025, Renovaro Inc. (the “ Company ”) received a deficiency notice from The Nasdaq Stock Market (“ Nasdaq ”) informing the Company that its common stock, par value $0.0001 per share (the “ Common Stock ”), fails to comply with the $1 minimum bid price required for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) based upon the closing bid price of the Common Stock for the 30 consecutive business days prior to the date of the notice from Nasdaq. Nasdaq’s notice has no immediate effect on the listing of the Common Stock on The Nasdaq Capital Market an”

urban-gro, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 16, 2025, urban-gro, Inc. (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) stating that because the Company had not yet filed its Annual Report on Form 10-K for the fiscal quarter ended December 31, 2024 (the “Form 10-K”), the Company is no longer in compliance with Nasdaq Listing Rule 5250(c)(1). Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission. As disclosed in the Current Report on Form 8-K filed by the Company on August 14, 2024, the Co”

Sharps Technology Inc. received a nasdaq compliance regained notice regarding other (rules 5608(b)(1), 5608(b)(2)).

“April 16, 2025, the Company received a letter from Nasdaq stating that because the Company failed to timely adopt the Policy as required by Listing Rule 5608(b)(1), and failed to disclose the Policy in its Form 10-K for the fiscal years ended December 31, 2023 or December 31, 2024 (prior to its amendment), the Company previously did not comply with Listing Rule 5608(b)(2). However, in the letter, Nasdaq further informed the Company that it is currently in compliance with Nasdaq Listing Rules, and the matter raised by Nasdaq in the letter is now closed.”

Fathom Holdings Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 14, 2025, Nasdaq Stock Market LLC (“Nasdaq”) notified Fathom Holdings Inc. (the “Company”) that for the last 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until October 13, 2025, to regain compliance with the Bid Price Rule. If at any time before October 13, 2025, the bid”

Onconetix, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5810(c)(3)(A)(iii)).

“April 14, 2025, Nasdaq issued a further notice (the “Notice”) to the Company that it determined that the Company’s securities had a closing bid price of $0.10 or less for ten consecutive trading days. Accordingly, the Company is subject to the provisions under Nasdaq Listing Rule 5810(c)(3)(A)(iii). As a result, unless the Company timely requests a hearing before the Nasdaq Hearings Panel (the “Panel”), trading of the Common Stock will be suspended at the opening of business on April 23, 2025, and a Form 25-NSE will be filed with the Commission, which will remove the Company’s securities from”

IP STRATEGY HOLDINGS, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“April 14, 2025, Heritage Distilling Holding Company, Inc. (the “Company”) received a notice (the “Notice”) from the Nasdaq Stock Market LLC (“Nasdaq”), which indicated that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Requirement”), as the Company’s closing bid price for its common stock, par value $0.0001 per share (the “Common Stock”), was below $1.00 per share for the prior thirty (30) consecutive business days. Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), the Company has been granted a 180-calendar day compliance period, or until October 1”

Aspire Biopharma Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“April 16, 2025, Aspire Biopharma Holdings, Inc. (the “Company”), received two letters from the Nasdaq Stock Exchange LLC (“Nasdaq”), each addressing a separate compliance deficiency under the Nasdaq Listing Rules. The first letter notified of the deficiency with regard to Rule 5450(b)(2)(A) (the “MVLS Notice”), which requires a company, whose securities are listed on The Nasdaq Global Market under the “Market Value Standard”, to maintain a minimum Market Value of Listed Securities (an “MVLS”) of $50,000,000. The deficiency was caused by the Company’s MVLS having been below the minimum level fo”

Aspire Biopharma Holdings, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(C)).

“April 16, 2025, Aspire Biopharma Holdings, Inc. (the “Company”), received two letters from the Nasdaq Stock Exchange LLC (“Nasdaq”), each addressing a separate compliance deficiency under the Nasdaq Listing Rules. The first letter notified of the deficiency with regard to Rule 5450(b)(2)(A) (the “MVLS Notice”), which requires a company, whose securities are listed on The Nasdaq Global Market under the “Market Value Standard”, to maintain a minimum Market Value of Listed Securities (an “MVLS”) of $50,000,000. The deficiency was caused by the Company’s MVLS having been below the minimum level fo”

Tenaya Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(A)).

“April 15, 2025, Tenaya Therapeutics, Inc. (the “Company”) received a letter from the Listing Qualifications Staff (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of shares of the Company’s common stock for the 30 consecutive business day period between March 3, 2025, through April 12, 2025, the Company did not meet the minimum bid price of $1.00 per share required for continued listing on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1). The letter also indicated that the Company will be provided with a complia”

Zeo Energy Corp. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 17, 2025, Zeo Energy Corp. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is not in compliance with periodic requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) because the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “2024 10-K”) was not filed with the Securities and Exchange Commission by the required due date of March 31, 2025. This Letter received from Nasdaq has no immediate effect on the listing or tradi”

TechTarget, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 17, 2025, the Company received a notification letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that, because the Company failed to timely file its 2024 Form 10-K with the Securities and Exchange Commission (the “SEC”), the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule”), which requires Nasdaq-listed companies to timely file all required periodic financial reports with the SEC. The Notice has no immediate effect on the listing or trading of the Company’s securities on Nasdaq. The Notice informe”

GRAFTECH INTERNATIONAL LTD received a nyse noncompliance notice notice regarding minimum bid price (rules 802.01C).

“April 15, 2025, GrafTech International Ltd. (the “Company”) received written notice (the “Notice”) from the New York Stock Exchange (the “NYSE”) that it is not in compliance with the continued listing standard set forth in Section 802.01C of the NYSE’s Listed Company Manual (“Section 802.01C”) because the average closing price of the Company’s common stock per the Notice was less than $1.00 per share over the consecutive 30 trading-day period ended April 14, 2025. The Notice does not result in the immediate delisting of the Company’s common stock from the NYSE. In accordance with applicable NY”

SPLASH BEVERAGE GROUP, INC. received a nyse_american noncompliance notice notice regarding late filing.

“not in compliance with NYSE American continued listing standards (the “Filing Delinquency Notification”) due to the failure to timely file the Company’s Form 10-K for the year ended December 31, 2024 (the “Delinquent Report”) by the filing due date of April 15, 2025 (the “Filing Delinquency”). The Company intends to file the Delinquent Report in the very near future, however, there is currently no anticipated date for when such Filing Delinquency will be cured via the filing of the Delinquent Report.. There can be no assurance that the Company will ultimately regain and remain in compliance wi”

Hepion Pharmaceuticals, Inc. received a nasdaq delisting notice notice regarding other.

“April 15, 2025, Hepion Pharmaceuticals, Inc., a Delaware corporation (the “ Company ”), received written notice (the “ Notice ”) from the Nasdaq Stock Market, LLC (“ Nasdaq ”) indicating that the Staff believes that the Company is a “public shell” and that the continued listing of its securities is no longer warranted. The Staff stated that this serves as an additional basis for delisting the Company’s securities from The Nasdaq Stock Market. The Notice is formal notification that the Nasdaq Hearings Panel (the “Panel”) will consider this matter in rendering a determination regarding the Compa”

ADVENT TECHNOLOGIES HOLDINGS, INC. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“April 16, 2025, Advent Technologies Holdings, Inc. (the “Company”) received a letter (the “Letter”) from the Listing Qualifications Department of the Nasdaq Stock Market (“Nasdaq”) notifying the Company that it is not in compliance with periodic requirements for continued listing set forth in Nasdaq Listing Rule 5250(c)(1) because the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024 (the “2024 10-K”) was not filed with the Securities and Exchange Commission by the required due date of March 31, 2025. This Letter received from Nasdaq has no immediate effect on th”

Vincerx Pharma, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)(iv)).

“April 14, 2025, Vincerx Pharma, Inc. (the “Company”) received written notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with Nasdaq listing rule 5550(a)(2) because the closing bid price of the Company’s common stock for the last 30 consecutive business days was lower than the minimum bid price requirement of $1.00 per share (the “Minimum Bid Price Requirement”). Pursuant to Nasdaq listing rule 5810(c)(3)(A)(iv), the Company is not eligible for any compliance period specified in Nasdaq listing rule 5810(c)(3)(A) because the Comp”

Motorsport Games Inc. received a nasdaq compliance regained notice regarding stockholders equity (rules 5550(b)(1)).

“April 15, 2025, Motorsport Games Inc. (the “Company”) received a letter from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) stating that based on the Company’s Form 8-K, as filed with the Securities and Exchange Commission (the “SEC”) on April 14, 2025, Nasdaq has determined that the Company now complies with the stockholders’ equity requirement as set forth in Nasdaq Listing Rule 5550(b)(1). As previously reported, on November 20, 2024, the Company received a letter from Nasdaq stating that the Company did not comply with the minimum $2.5 million stockholders’ equ”

ESH Acquisition Corp. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A)).

“April 11, 2025, ESH Acquisition Corp. (the “Company”) received a notice from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that, for the prior 30 consecutive business days (through April 10, 2025), the closing market value of listed securities (MVLS) of the Company’s Class A Common Stock (“Class A Shares”), had been below the minimum of $50 million required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A). The notice stated that the Company would be afforded 180 calendar days (until October 8, 2025) to regain co”

Newton Golf Company, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 14, 2025, Newton Golf Company Inc. (the “Company”) received a deficiency letter (the “Notice”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with Nasdaq Listing Rule 5550(b)(1) which requires the Company to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing on The Nasdaq Capital Market (the “Stockholders’ Equity Requirement”). As disclosed in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2025, the deficiency in the Stockholders’ Equity Re”